SymbolPROK
NamePROKIDNEY CORP.
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
Address2000 FRONTIS PLAZA BLVD.,SUITE 250, WINSTON-SALEM, North Carolina, 27103, United States
Telephone+1 336 - 999-7019
Fax
Email
Websitehttps://www.prokidney.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001850270
Description

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patients own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patients own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.

Additional info from NASDAQ:
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patients own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patients own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.

2026-07-06 20:02

Locke Kenneth Thomas 🟢 acquired 750.0K shares (1 derivative) of PROKIDNEY CORP. (PROK) at $1.89 ($1.4M) Transaction Date: Jul 01, 2026 | Filing ID: 296160

Read more
2026-06-15 21:32

Girolamo Todd C 🟡 adjusted position in 163.9K shares (2 derivative) of PROKIDNEY CORP. (PROK) Transaction Date: Jun 12, 2026 | Filing ID: 271337

Read more
2026-06-10 17:06

New Form 3 - PROKIDNEY CORP. <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001193125-26-265815 <b>Size:</b> 22 KB

Read more
2026-06-02 12:00

ProKidney Appoints Kenneth Locke as Chief Technical Officer

Read more
2026-05-29 20:07

Lotvin Alan 🟢 acquired 135.0K shares (1 derivative) of PROKIDNEY CORP. (PROK) at $1.81 Transaction Date: May 28, 2026 | Filing ID: 248262

Read more
2026-05-29 20:06

Jimenez Santos Jose Ignacio 🟢 acquired 135.0K shares (1 derivative) of PROKIDNEY CORP. (PROK) at $1.81 Transaction Date: May 28, 2026 | Filing ID: 248259

Read more
2026-05-29 20:06

Fox Jennifer A. 🟢 acquired 135.0K shares (1 derivative) of PROKIDNEY CORP. (PROK) at $1.81 Transaction Date: May 28, 2026 | Filing ID: 248256

Read more
2026-05-29 20:05

DOYLE WILLIAM F 🟢 acquired 135.0K shares (1 derivative) of PROKIDNEY CORP. (PROK) at $1.81 Transaction Date: May 28, 2026 | Filing ID: 248249

Read more
2026-05-29 20:04

Sinha Uma 🟢 acquired 135.0K shares (1 derivative) of PROKIDNEY CORP. (PROK) at $1.81 Transaction Date: May 28, 2026 | Filing ID: 248226

Read more
2026-05-29 20:04

Legorreta Pablo G. 🟢 acquired 135.0K shares (1 derivative) of PROKIDNEY CORP. (PROK) at $1.81 Transaction Date: May 28, 2026 | Filing ID: 248221

Read more